Skip to main content
Livermore
Livermore
ZHEN

Affinity Capital Advisors, LLC

SEC CIK
0001810023
Latest filing
Jul 8, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Affinity Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
3,760
Value
$957.9K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Affinity Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,760$957.9K0.1%−58−1.5%ReducedHolders
Q1 20263,818$830.4K0.1%−187−4.7%ReducedHolders
Q4 20254,005$915.1K0.1%+564+16.4%AddedHolders
Q3 20253,441$814.1K0.1%+8+0.2%AddedHolders
Q2 20253,433$637.2K0.1%+10+0.3%AddedHolders
Q1 20253,423$599.2K0.1%+4+0.1%AddedHolders
Q4 20243,419$613.9K0.1%+9+0.3%AddedHolders
Q3 20243,410$673.3K0.1%+8+0.2%AddedHolders
Q2 20243,402$583.6K0.1%−25−0.7%ReducedHolders
Q1 20243,427$624.0K0.1%+37+1.1%AddedHolders
Q4 20233,390$525.4K0.1%−55−1.6%ReducedHolders
Q3 20233,445$513.5K0.1%+173+5.3%AddedHolders
Q2 20233,272$440.9K0.1%+53+1.6%AddedHolders
Q1 20233,219$513.1K0.2%−30−0.9%ReducedHolders
Q4 20223,249$525.0K0.2%+6+0.2%AddedHolders
Q3 20223,243$435.0K0.2%+5+0.2%AddedHolders
Q2 20223,238$496.0K0.2%−43−1.3%ReducedHolders
Q1 20223,281$532.0K0.2%+54+1.7%AddedHolders
Q4 20213,227$437.0K0.1%+10.0%AddedHolders
Q3 20213,226$348.0K0.1%+10.0%AddedHolders
Q2 20213,225$363.0K0.1%+236+7.9%AddedHolders
Q1 20212,989$323.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.